19-44516978-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001102597.3(CEACAM20):c.1277C>T(p.Ala426Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000505 in 1,598,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001102597.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM20 | NM_001102597.3 | c.1277C>T | p.Ala426Val | missense_variant | 6/12 | ENST00000614924.5 | NP_001096067.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM20 | ENST00000614924.5 | c.1277C>T | p.Ala426Val | missense_variant | 6/12 | 1 | NM_001102597.3 | ENSP00000481937 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152168Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000432 AC: 96AN: 222168Hom.: 0 AF XY: 0.000409 AC XY: 49AN XY: 119782
GnomAD4 exome AF: 0.000526 AC: 761AN: 1446676Hom.: 0 Cov.: 32 AF XY: 0.000474 AC XY: 340AN XY: 717974
GnomAD4 genome AF: 0.000309 AC: 47AN: 152286Hom.: 0 Cov.: 31 AF XY: 0.000255 AC XY: 19AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.1277C>T (p.A426V) alteration is located in exon 6 (coding exon 6) of the CEACAM20 gene. This alteration results from a C to T substitution at nucleotide position 1277, causing the alanine (A) at amino acid position 426 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at